Sector
PharmaceuticalsOpen
₹2,150Prev. Close
₹2,136.35Turnover(Lac.)
₹1.73Day's High
₹2,140Day's Low
₹2,15052 Week's High
₹052 Week's Low
₹0Book Value
₹328.57Face Value
₹10Mkt Cap (₹ Cr.)
1,081.48P/E
20.04EPS
106.87Divi. Yield
1.19No Record Found
| Y/e 31 Mar( In .Cr) | Dec-2010 | Dec-2009 |
|---|---|---|
Equity Capital | 5.05 | 5.05 |
Preference Capital | 0 | 0 |
Reserves | 160.88 | 125.04 |
Net Worth | 165.93 | 130.09 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,916.85 | 165.25 | 4,59,916.52 | 237.82 | 0.7 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,547 | 88.65 | 1,47,255.42 | 430 | 0.54 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,640.6 | 33.36 | 1,32,489.44 | 1,055.94 | 0.79 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,519.45 | 79.25 | 1,19,108.83 | 469 | 0.8 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,659.65 | 26.98 | 1,11,134.21 | 1,417.2 | 0.6 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Roland Kaut
Director
D G Rajan
Director
S N Talwar
Director
M S Grewal
Company Secretary
Manish A Mestry
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Solvay Pharma India Ltd merged
Summary
Solvay Pharma India Ltd is an India-based pharmaceutical company. The company is present in the pharmaceutical sector and operates in the field of womens health, gastroenterology, mental health and influenza vaccines. They do not have any manufacturing plant / facilities. The manufacturing activities are carried out by different parties on loan license basis. The companys product range includes gastroenterology, gynaecology, mental health, vaccines and others. Their gastroenterology products include duphalac solution, creon capsules, Colospa tablets and Retard Capsules, Pankreoflat tablets, udiliv tablets and Bdlcel tablets. Their mental health products include vertin tablets and uvox and ebasil. They produce Influvac injection, duodil and colossal iodine oral.Solvay Pharma India Ltd was incorporated on January 24, 2000 as Duphar Pharma India Ltd. Pursuant to the de-merger, the pharma business of Duphar-Interfran Ltd was transferred to the company with effect from April 1, 2000. The name of the company was changed from Duphar Pharma India Ltd to Solvay Pharma India Ltd with effect from April 15, 2002. In the year 2002, the company acquired Duvadilan brand from the parent company Solvay Pharmaceuticals B. V., The Netherlands for a consideration of Rs 14.25 crore. They launched a specialty division consisting of 130 field personnel, for achieving a better focus on promotion of certain products.In February 2003, the company acquired eight Pharmaceutical Brands/ marketing rights
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
